Australia markets closed

Cellebrite DI Ltd. (CLBT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.71+0.24 (+2.29%)
At close: 04:00PM EDT
10.70 -0.01 (-0.09%)
After hours: 06:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.47
Open10.49
Bid10.69 x 300
Ask10.75 x 100
Day's range10.48 - 10.71
52-week range5.22 - 12.50
Volume483,137
Avg. volume976,775
Market cap2.199B
Beta (5Y monthly)1.53
PE ratio (TTM)N/A
EPS (TTM)-0.43
Earnings date15 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.58
  • GlobeNewswire

    Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2024 financial results before market open on Thursday, May 23, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2024 and discuss its 2024 outlook

  • Simply Wall St.

    What Does Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price Indicate?

    Cellebrite DI Ltd. ( NASDAQ:CLBT ), is not the largest company out there, but it received a lot of attention from a...

  • GlobeNewswire

    Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership

    Appointment Builds on the Momentum Behind Cellebrite’s Preeminent Case-to-Closure Platform and Market-Leading Investigative Solutions to Accelerate Justice David Gee, Cellebrite Chief Marketing Officer David Gee was appointed Chief Marketing Officer at Cellebrite. TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 25, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd (Nasdaq: CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the appointment of